Company ProfilePremium

KEWPIE CORPORATION

Company Profile Analysis

Ticker: 2809.Tキユーピー株式会社

ESOMAR 23 Corporate BadgeISO Certifications Badge
KEWPIE CORPORATION - Healthcare showcase

Year Founded & Workforce

1919

10,773 Employees

Industry

Healthcare

Services

Hyaluronic acid
KEWPIE CORPORATION logo

KEWPIE CORPORATION Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

KEWPIE CORPORATION Overview

Kewpie Corporation is Japan's dominant mayonnaise and salad-dressing franchise and, through its egg-processing operations, the country's largest industrial user and processor of eggs. Founded in 1919 and maker of Japan's first domestically produced mayonnaise (1925), the group has evolved into a vertically integrated "salads and eggs" company spanning retail condiments, chilled delicatessen and packaged salads, food-service sauces and liquid/frozen/dried egg products, jams (Aohata), fine chemicals (hyaluronic acid, egg yolk lecithin) and food machinery. Roughly 80% of revenue is domestic and mature, but the Overseas segment (19.5% of FY2025 sales, 13.6% operating margin) generates over 30% of segment profit and is the designated growth engine, with new capacity in the U.S. (Tennessee), China and Southeast Asia. Under the FY2025–FY2028 "Change & Challenge" plan, management targets JPY 600bn sales, JPY 45bn operating income and ROE of at least 8.5% by FY2028, pursued through domestic structural reform, price discipline and global brand expansion.


What the company does — company's own description

In its FY2025 consolidated financial statements, Kewpie organises its operations into six reporting segments according to market. The company's own segment descriptions (FY2025 Kessan Tanshin, segment note) are:

Retail Market: manufactures and sells mayonnaise, dressings, pasta sauces, salads, delicatessen foods, packaged salads, baby foods and nursing-care foods for the retail market.

Food Service: manufactures and sells mayonnaise, dressings, vinegar, liquid egg, frozen egg, dried egg and egg-processed foods for the food-service market.

Overseas: manufactures and sells mayonnaise and dressings in overseas markets including China, Southeast Asia and North America.

Fruit Solutions: manufactures and sells jams and frozen processed fruit for household use and fruit-processed foods for industrial use.

Fine Chemicals: manufactures and sells hyaluronic acid and egg yolk lecithin used as ingredients for pharmaceuticals, cosmetics and food products.

Common Business: sale of food products and food-production equipment.

The group's stated ideal is to contribute to "the food culture and health of the world through great taste, empathy, and uniqueness", and its 2030 Vision (as restated in the Medium-Term Plan, Nov 2024) has three pillars: "Leading Company for Salads and Eggs", "Food Partner for Every Person" and "Supporter for Bringing Smiles to Children".

Business model and revenue model

Revenue engineNatureFY2025 scale (JPY Bn)Comment
Branded retail condiments (mayonnaise, dressings, sauces)Branded consumer packaged goods77.5Highest-margin domestic franchise; FY2025 segment OI 8.5
Delicatessen / chilled saladsBranded and customer-specified chilled foods65.4Low-to-mid single-digit margin
Cut vegetables / packaged saladsFresh produce processing (Salad Club)30.0Volatile; weather-driven
Food-service condimentsB2B branded and custom sauces53.2Restaurant, delicatessen, CVS channels
Egg productsB2B liquid/frozen/dried egg and processed egg115.8Largest single sub-business; egg-price pass-through
OverseasBranded KEWPIE mayonnaise and dressings, plus contract manufacturing100.3Highest-margin segment (13.6%)
Fruit Solutions (Aohata)Jams, spreads, industrial fruit17.6Wholly owned from Nov 2025
Fine ChemicalsB2B ingredients plus direct mail-order supplements11.8Hyaluronic acid, lecithin, acetic acid bacteria supplements
Common BusinessMachinery and raw-material sales8.3External machinery sales

Kewpie is overwhelmingly a product business. Revenue is generated from the manufacture and sale of branded and private-specification food products and ingredients; there is no material subscription or licensing revenue disclosed. Within the product mix, the main economic engines are:

Source: Supplementary Data for 1H FY2026 (FY2025 columns), FY2025 Kessan Tanshin.

A small but growing direct-to-consumer element exists through Fine Chemicals' mail-order supplement sales (cited as a driver of segment growth in FY2025 and 1H FY2026). No customer accounted for 10% or more of consolidated net sales in FY2024 or FY2025 (FY2025 Kessan Tanshin, "Information by major customer").

Value-chain position

Kewpie occupies the processing and branded-manufacturing stage of the food value chain, sitting between agricultural/commodity inputs (eggs, edible oils, vinegar, vegetables, fruit) and distribution (supermarkets, convenience stores, restaurants, delicatessen operators, e-commerce). Its integration is unusually deep for a condiment maker:

Upstream: Kewpie Egg Corporation (egg breaking/processing; production and purchasing company for egg products), Kewpie Jozo (vinegar), and in-house use of by-products (egg shells, egg yolk → lecithin; egg membranes; unused vegetable portions — 88.0% effective utilisation rate in 1H FY2026).

Midstream: mayonnaise/dressing plants (Japan, U.S., China, Southeast Asia, Poland), chilled delicatessen (Deria Foods, Shunsai Deli), cut vegetables (Salad Club), fruit processing (Aohata), packaging (Kepack), machinery (Shiba Seisakusho).

Logistics: historically in-house; K.R.S. Corporation (Kewsoe) was partly sold in January 2021 and is now an equity-method affiliate (Kewpie holds 43.29%).

Downstream: own sales force for retail and food-service; KEWPIE brand marketing overseas.

Customer types and end-markets

Customer typeSegment(s)Examples of channel
Households (via retailers)Retail Market, Overseas, Fruit SolutionsSupermarkets, drugstores, CVS, e-commerce
Restaurants and food-service operatorsFood Service, OverseasChains, delicatessen counters, bakeries, CVS food makers
Food manufacturers / industrialFood Service (egg), Fruit Solutions (industrial fruit), Fine ChemicalsBakeries, confectioners, prepared-food makers
Pharmaceutical and cosmetics makersFine ChemicalsHyaluronic acid, egg yolk lecithin
Consumers directFine Chemicals (mail order)Supplements
Third-party brand ownersOverseas (U.S. contract manufacturing)Q&B Foods co-packing

Independent characterisation

Kewpie is best understood as a mature, high-share domestic franchise funding an international brand build. The Japanese condiment business is price-led rather than volume-led — 1H FY2026 household salad-condiment volume was flat at 62 thousand tonnes while unit price rose 6% to JPY 655/kg (Supplementary Data 1H FY2026). Earnings volatility is dominated by two commodity inputs: edible oil (soybean/rapeseed) and eggs, the latter exposed to highly pathogenic avian influenza (HPAI) cycles. The FY2023 earnings trough (operating income JPY 19.7bn, margin 4.3%) and the FY2024 rebound (JPY 34.3bn, 7.1%) illustrate the lag between input-cost shocks and price pass-through. The structural thesis rests on (a) restored domestic pricing power, (b) value-added mix shift (e.g., egg products, "Kewpie Half"), and (c) the KEWPIE brand's growing recognition abroad, particularly in the Americas and Asia-Pacific.

Strategy

Stated strategy — themes from the latest plan and reports

Long-term vision (2030 Vision): "Leading Company for Salads and Eggs"; "Food Partner for Every Person" (connecting with each customer and enhancing quality of life through products, expertise and services); "Supporter for Bringing Smiles to Children". The 2030 Vision page adds the aim of spreading the salad culture cultivated in Japan globally and using DX, including AI, to evolve the value chain.

Medium-Term Business Plan FY2025–FY2028: "—Change & Challenge— Improving management efficiency in mature markets and accelerating investment in growth areas."

Economic-value pillars: "Structural reform of domestic business" (profitability) and "Acceleration of global expansion" (growth), underpinned by portfolio transformation and SCM productivity, DX-driven value creation, business-area expansion and brand value, and a foundation for global management.

Social-value pillars: "Contributing to food culture and health", "Consideration for the environment", "Enhancing the value of human capital".

Capital policy: "Management with an awareness of the cost of capital and stock price."

FY2026 positioning (FY2025 Kessan Tanshin): an "important year for further accelerating measures for growth" — proactive demand creation overseas to translate FY2025 plant investments into results; domestically, reasonable price revisions, automation and digitalisation, and fundamental business-structure reforms involving reorganisation.

2026 marketing theme: "CROSS" — crossing retail and food-service know-how to create food trends that move from restaurants to the home (new product strategy briefing, 27 Jan 2026).

Medium-term financial targets (FY2028)

TargetFY2024 actualFY2025 actualFY2026 forecastFY2028 target
Net sales (JPY bn)484.0513.4530.0600.0
Operating income (JPY bn)34.334.638.045.0
Operating margin (%)7.16.77.27.5
ROE (%)7.39.78.0≥8.5
ROIC (%)6.86.67.1≥8.5
Domestic business profit margin (%)7.26.67.3≥8.0
Overseas sales growth, local currency (%)1189≥10 CAGR
Overseas net sales (JPY bn)93.1100.3116.5180.0
SegmentFY2024 salesFY2028 sales targetSales CAGRFY2024 OIFY2028 OI target
Retail Market186.3196.01%13.715.6
Food Service171.5179.01%12.614.1
Overseas93.1180.018%12.218.0
Other35.145.06%1.84.3
Company-wide———-6.3-7.0
Total486.0600.05%34.045.0

Sources: MTP briefing (26 Nov 2024); Supplementary Data 1H FY2026; FY2025 results briefing (Japanese).

FY2028 targets by segment (JPY bn, MTP reference page)

FY2024 figures here are the MTP-time forecasts, not final actuals.

Investment and capital-allocation framework (FY2025–FY2028)

ItemAmount (JPY Bn)
Capital investment total100.0 (1.8x previous plan's 70.0)
– Aggressive investment (growth, value-add, automation, location optimisation, DX, new development, sustainability)75.0
– Business continuity investment25.0
– Of which overseas growth investment30.0
Proactive future investment (expensed: human capital, brand, DX, R&D, sustainability)20.0
Operating cash flow (4-year)c.170.0
Shareholder returnsc.50.0
PolicyTotal return ratio ≥50% over 4 years; minimum DPS JPY 54 raised gradually; flexible buybacks (JPY 10bn indicated); M&A and alliances considered
Financial disciplineEquity ratio target 60%; interest-bearing debt/EBITDA <2x; cost of equity recognised at 4–6%

Strategic initiatives announced in the last 24 months

DateInitiativeDescription / target
Oct 2024Marketing organisation integrationRetail and food-service marketing merged to create trends in food service and roll out to retail
Nov 2024MTP FY2025–FY2028See above
FY2025Overseas brand programmeOverseas branding under unified concept for mayonnaise 100th anniversary; advertising up to JPY 13.2bn
Feb 2025Restricted stock compensationAligns directors with shareholders
May 2025Tennessee plantSecond U.S. base; long-term hub for the Americas
Jun 2025Baby-food exit72 items discontinued by end Aug 2026 citing difficulty maintaining satisfactory quality amid declining volumes and rising raw-material/energy costs
Jul 2025Aohata full ownershipFaster decision-making and resource sharing
FY2025Domestic automationRobot introduction for production; "smart factory" concept
Jan 2026JPY 10bn buybackUp to 4m shares (2.87%) through 30 Nov 2026
Jan 2026"CROSS" product strategyRetail × food service
Jan–Feb 2026Product renewals/launchesThousand Island renewal; Gutappuri Sauce negi-shio; Lemon Tartar
Apr & Nov 2026Price revisionsApril 2026 (up to c.24%), November 2026 (household 3–25%; commercial 2–38%)
Jul 2026Egg-products sales integrationKewpie to take over Kewpie Egg's egg-processed-products sales business (c.JPY 7.8bn, effective 1 Dec 2026); Kewpie Egg to become a production/purchasing company

Sustainability commitments (domestic targets)

CO2 reduction ≥46% by FY2028 and ≥50% by FY2030 vs FY2013; plastic reduction ≥25% (FY2028) and ≥30% (FY2030) vs FY2018; food-waste reduction ≥63%/65% vs FY2015; water intensity ≥8%/10% vs FY2020; 100% sustainable paper; engagement score ≥75 points.

Products & Services

Kewpie does not publish SKU-level revenue or pricing beyond reference retail prices for certain items. Where a launch date or price is not disclosed in reviewed sources it is marked n/d.

Retail Market segment

Product / brandDescription & capabilitiesTarget customerLaunch / latest versionPricing (disclosed)
Kewpie MayonnaiseEgg-yolk mayonnaise; flagship of the groupHouseholdsLaunched Mar 1925450g reference retail price JPY 559, rising to JPY 611 from 1 Nov 2026 shipments (Kyodo, 1 Sep 2026)
Kewpie Half (calorie-cut mayonnaise type)Reduced-calorie mayonnaise-type dressing; targeted with strengthened sales promotion in FY2025Health-conscious households——
Kewpie Deep-Roasted Sesame DressingCreamy roasted-sesame dressing; designated "global strategic product"Households (Japan and overseas)——
Kewpie Thousand Island DressingCreamy dressing with pickle notes; No.1 sales-composition flavour in the red-cap series; renewed with improved sweet-sour balance and egg-yolk richnessHouseholdsLaunched 1963; renewed 19 Feb 2026—
French Dressing (red/white)Kewpie's first dressingsHouseholdsPre-1963—
Kewpie Non-oil dressingsOil-free dressing range (featured in the 2024 "Dressing & Non-oil General Election" consumer campaign)Health-conscious households——
Pasta saucesReady-to-use pasta saucesHouseholds——
Delicatessen (Deria brand, Deria Foods / Shunsai Deli)Chilled salads and side dishes; MTP strategy is a shift to "strong products" and robot automationSupermarkets, CVS, householdsOngoing—
Packaged salads / cut vegetables (Salad Club)Pre-cut, washed vegetables and salad kits; value-added development and new materialsSupermarkets, CVSOngoing—
Nursing-care foodsTexture-modified meals for the elderlyElderly and carers——
Baby food / infant food (72 items incl. jars, "Nikoniko Box" cup meals, "Happy Recipe" pouches, baby desserts, egg boro snacks, "Yasai to Nakayoshi" sauces and spreads)Infant weaning foodsParentsLaunched 1960; production ended end Aug 2026—

Food Service segment

Product / brandDescription & capabilitiesTarget customerLaunch / latestPricing
Food-service mayonnaise and dressingsBulk and portion formatsRestaurants, delis, CVS food makersOngoing601 commercial items raised c.2–38% from 1 Nov 2026
"Gutappuri Sauce" (具たっぷりソース) seriesProprietary process so chunky sauce "sits on" food without soaking in; yuzu soy and garlic onion (Feb 2024), yakiniku (Feb 2025), negi-shio (Feb 2026) — 5 items in totalRestaurants, multiple formatsFirst launched Feb 2024; negi-shio 6 Feb 2026—
"Kewpie Gutakusan Sauce Lemon Tartar"Lemon-juice and peel tartar sauce for summer menusRestaurants, delis6 Feb 2026—
Vinegar (Kewpie Jozo)Brewed vinegarsFood makers, restaurantsOngoing—
Liquid egg, frozen egg, dried eggIndustrial egg ingredients from Kewpie EggBakeries, confectioners, food processorsOngoingPass-through of egg market prices
Egg-processed foodsValue-added egg products (e.g., cooked egg items) — grew in volume in 1H FY2026CVS, restaurants, delisOngoing—

Overseas segment

Product / brandDescriptionMarketsNotes
KEWPIE MayonnaiseJapanese-style egg-yolk mayonnaise; global strategic productChina ("丘比"), Southeast Asia, Asia-Pacific, Americas, EuropeOverseas branding under unified concept from 100th anniversary
KEWPIE Deep-Roasted Sesame DressingGlobal strategic product; one of the top sellers in the U.S.U.S., AsiaProduced at Irwindale and Clarksville
Local-recipe dressings and saucesProducts tailored to local cuisines ("proposal-based promotions in tune with local cuisine")China, Southeast Asia—
Contract manufacturingMayonnaise, dressings and sauces for other companiesU.S. (Q&B Foods)Tennessee plant licensed for contract work

Fruit Solutions segment (AOHATA Corporation)

ProductDescriptionTargetNotes
Household jams and spreads (Aohata brand, including the low-sugar "Aohata 55" line)Jams, fruit spreadsHouseholdsStrong sales cited in FY2025 and 1H FY2026
Frozen processed fruitHousehold frozen fruitHouseholds—
Industrial fruit-processed foodsFruit preparations for food makersFood manufacturersStrong in FY2025

Fine Chemicals segment

ProductDescriptionTargetNotes
Hyaluronic acid (ingredient)Produced from egg-derived/fermentation processes for pharma, cosmetics, foodPharma, cosmetics, supplementsB2B
Hyaluronic acid supplements (mail order)Direct-to-consumer supplementsConsumersMail order strong in FY2025 and 1H FY2026
Acetic acid bacteria supplementsFunctional supplementConsumersCited as driver in 1H FY2026
Egg yolk lecithinPhospholipid ingredient for pharmaceuticals (e.g., emulsions), cosmetics, foodPharmaPharmaceutical-ingredient volumes declined in FY2025

Common Business

Product / serviceDescriptionCustomer
Food-production machinery (Shiba Seisakusho)Machinery for food and pharma production; external sales grew in FY2025Food manufacturers
Raw material and food product salesTrading of materialsGroup and third parties

Media and services

AssetDescription
"Kewpie 3-Minute Cooking"Long-running TV cooking programme; recipes now integrated into a LINE-based menu-suggestion service ("Recipe Talk", June 2025 coverage)
Shareholder benefit programmeGroup products worth JPY 1,000–5,000 depending on holding size and tenure (Integrated Report 2026)

Financial Narrative

Basis: Japanese GAAP, JPY millions unless stated. FY2021–FY2023 income statement data from company filings as compiled by Envalith/StockAnalysis (S&P Global) and cross-checked against company Supplementary Data; FY2024–FY2025 from the FY2025 Kessan Tanshin. FY2021 net sales are not comparable to FY2020 (JPY 531.1bn) because of the new revenue-recognition standard and the deconsolidation of K.R.S. in FY2021.

Income statement

Note: company Supplementary Data reports D&A of JPY 16.9bn for FY2023 (vs 17.1bn per S&P compilation); EBITDA for FY2024–FY2025 here uses filing D&A (JPY 17,536m and 18,291m), whereas some aggregators show JPY 52,047m and 52,927m.

FY2021 EPS derived (net income / c.140.6m average shares implied by S&P per-share data) — not taken from a filing. No dilutive securities exist, so diluted EPS equals basic. FY2025 DPS of JPY 64 includes JPY 10 commemorating the 100th anniversary of Kewpie Mayonnaise (JPY 5 interim + JPY 5 year-end). Sources: Supplementary Data FY2024 (FY2022–FY2024), FY2025 Kessan Tanshin, MTP briefing (FY2021–FY2024 DPS).

Revenue CAGR FY2021–FY2025: 6.0% per annum (JPY 407.0bn → JPY 513.4bn). Operating income CAGR over the same period: 5.5%. Net income CAGR: 14.1% (flattered by the FY2025 property gain).

Commentary — income statement. The five-year arc is a V-shape in profitability around an uninterrupted top-line climb. Sales grew every year (5.7%, 5.8%, 6.4%, 6.1%), but almost entirely through price rather than volume: domestic household salad-condiment volume moved from 124k tonnes (FY2022) to 120k (FY2023) and 123k (FY2024) while value rose from JPY 68.1bn to JPY 76.5bn (Supplementary Data FY2024). Gross margin compressed from 30.5% (FY2021) to 26.9% (FY2023) as edible-oil prices peaked (institutional oil averaging JPY 437/kg in 4Q FY2022) and HPAI drove the Tokyo medium-egg benchmark to JPY 348/kg in 2Q FY2023. FY2024 marked the inflection: gross margin rebounded to 30.5% and operating income rose 74.3% as raw-material relief (+JPY 11.5bn tailwind from main raw materials per company bridge) combined with earlier price revisions. FY2025 was a "run to stand still" year at the operating line (+0.9%): the company's bridge shows JPY 13.7bn of self-generated "earning power" (price revisions +8.8bn, overseas and other sales growth +3.9bn, value-added +1.8bn, production efficiency +0.3bn) offset by JPY 11.9bn of "intensifying headwinds" — chiefly eggs (benchmark JPY 287–334/kg) and logistics (FY2025 results briefing script, Japanese version). Net income jumped 42.4% because of a JPY 12.1bn gain on the sale of a former factory site. SG&A has grown faster than sales (FY2021–FY2025 CAGR 4.8% vs sales 6.0% — actually slower; SG&A ratio fell from 23.6% to 22.7%), with advertising rising from JPY 10.3bn (FY2023) to JPY 13.2bn (FY2025) to support overseas brand building.

Balance sheet

Sources: FY2024–FY2025 FY2025 Kessan Tanshin; FY2021–FY2023 S&P Global via StockAnalysis, cross-checked with company Supplementary Data (net assets, equity, equity ratio). Company-defined "interest-bearing debt" (which includes all interest-bearing liabilities incl. current leases) was JPY 33,042m (FY2022), 32,550m (FY2023), 22,422m (FY2024) and 29,745m at 31 May 2026; the S&P-compiled totals above differ slightly. Net debt uses cash and deposits plus short-term securities.

Commentary — balance sheet. Kewpie runs a deliberately conservative balance sheet: a 67.4% equity ratio and a net cash position of roughly JPY 60bn at FY2025. Under the MTP the company explicitly states that its cost of equity is 4–6% and that it will "utilize interest-bearing debt within the scope of financial discipline" (target equity ratio 60%, interest-bearing debt/EBITDA below 2x). The FY2025 decline in cash (JPY 78.1bn → 65.6bn) reflects JPY 16.3bn of buybacks, JPY 8.8bn of dividends, JPY 3.4bn of dividends to minorities, and JPY 19.4bn placed into time deposits (reclassified into "other investments", i.e., cash was redeployed rather than consumed). Two structural changes stand out in FY2025: (1) non-controlling interests fell JPY 5.8bn as Aohata became wholly owned via treasury shares, with capital surplus reduced by JPY 10.8bn; and (2) assets for retirement benefits rose JPY 11.85bn to JPY 46.4bn on pension-plan overfunding. Investment securities (JPY 55.6bn) include cross-shareholdings that the MTP flags for sale. Goodwill is negligible; the group has grown organically.

Cash flow

Sources: FY2025 Kessan Tanshin; Supplementary Data FY2024 (company FCF FY2022–FY2024, capital investments FY2023–FY2024); S&P Global via StockAnalysis (FY2021–FY2023 detail). FY2021 company-definition FCF derived. FY2025 company-definition FCF: 31,802 − 16,905.

Commentary — cash flow. Operating cash flow is lumpy because working capital swings with commodity prices: FY2024 OCF of JPY 63.1bn was inflated by a JPY 11.5bn increase in trade payables and a JPY 4.2bn release of inventories, which then partly reversed in FY2025 (payables −0.4bn, inventories −2.0bn, receivables −2.2bn) while cash taxes doubled to JPY 10.5bn on higher profits. Normalising across FY2024–FY2025, OCF averages roughly JPY 47bn, consistent with the MTP's four-year OCF assumption of about JPY 170bn (c.JPY 42.5bn per year). Capex peaked in FY2024 (JPY 18.1bn tangible, 5.8bn intangible incl. core IT systems) as the Tennessee, Thailand, Indonesia and China plants were built; FY2026 capital investment is guided to JPY 26.2bn, implying a step-up as the MTP's JPY 100bn four-year envelope is executed. FY2025 investing cash flow was flattered by JPY 11.2bn of proceeds from the former factory site sale.

Ratios

Sources: ROE, company ROA, ROIC, interest coverage (company), payout — company Supplementary Data FY2024 and FY2025 Kessan Tanshin (company ROIC = OI × (1 − effective tax rate) / (net assets + interest-bearing debt)). Net-income ROA from Envalith compilation. All other ratios derived from the tables above (year-end balances; DIO and DPO on cost of sales).

Commentary — ratios and returns. ROE reached 9.7% in FY2025, already above the FY2028 MTP target of 8.5%, but this was assisted by the one-off property gain; the company's own FY2026 forecast is ROE 8.0% and ROIC 7.1% (Supplementary Data 1H FY2026), implying that the underlying ROE is still converging on target. The ROIC target of at least 8.5% by FY2028 is the more demanding hurdle. Working-capital efficiency improved markedly in FY2024 (CCC 48 days vs 63 days in FY2023) as inventories normalised after the egg crisis and payables lengthened. Leverage metrics are not a constraint on any plausible strategy: the group could add c.JPY 100bn of debt before approaching its own 2x debt/EBITDA ceiling.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment net sales (JPY Bn)

Segment net sales (JPY Bn)FY2023FY2024FY2025FY2026F

Retail Market

177.4186.7189.8191.0

Food Service

165.3170.1185.6186.0

Overseas

78.392.2100.3116.5

Fruit Solutions

17.017.017.618.5

Fine Chemicals

11.211.411.812.5

Common Business

6.06.68.35.5

Total

455.1484.0513.4530.0

Segment growth (%)

Segment growth (%)FY2024FY2025FY2026F

Retail Market

5.31.60.6

Food Service

2.99.10.2

Overseas

17.88.716.2

Fruit Solutions

0.03.45.3

Fine Chemicals

1.84.05.6

Common Business

10.026.9-33.7

Total

6.46.13.2

Segment share of sales (%)

Segment share of sales (%)FY2023FY2024FY2025

Retail Market

39.038.637.0

Food Service

36.335.136.1

Overseas

17.219.019.5

Fruit Solutions

3.73.53.4

Fine Chemicals

2.52.42.3

Common Business

1.31.41.6

Revenue by Segment

Segment OI, old allocation basis (JPY Bn)FY2023FY2024

Retail Market

10.014.3

Food Service

4.212.0

Overseas

10.314.4

Fruit Solutions

0.30.2

Fine Chemicals

1.10.6

Common Business

1.31.4

Company-wide expenses

-7.3-8.4

Total

19.734.3

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Revenue by Segment (FY2024–FY2026F)

Segment OI, new allocation basis (JPY Bn)FY2024FY2025FY2026F

Retail Market

14.312.613.9

Food Service

12.011.913.2

Overseas

12.513.614.8

Fruit Solutions

0.20.70.7

Fine Chemicals

0.60.71.0

Common Business

1.41.41.2

Company-wide expenses

-6.5-6.1-6.8

Total

34.334.638.0

Segment operating margin (%)

Segment operating margin (%)FY2024FY2025FY2026F

Retail Market

7.66.67.3

Food Service

7.06.47.1

Overseas

13.513.612.7

Fruit Solutions

1.23.93.8

Fine Chemicals

5.06.08.0

Common Business

21.216.321.8

Consolidated

7.16.77.2

Sub-segment net sales (JPY Bn)

Sub-segment net sales (JPY Bn)FY2024FY2025FY2026F

Retail – Condiments

77.577.579.8

Retail – Delicatessen

65.365.466.6

Retail – Cut vegetables

28.630.030.0

Retail – Other

15.316.914.6

Food Service – Condiments

52.053.254.3

Food Service – Egg

101.6115.8115.5

Food Service – Other

16.516.716.2

Sub-segment operating income (JPY Bn)

Sub-segment operating income (JPY Bn)FY2024FY2025FY2026F

Retail – Condiments

10.28.58.7

Retail – Delicatessen

3.12.83.2

Retail – Cut vegetables

0.90.81.6

Retail – Other

0.20.50.4

Food Service – Condiments

3.74.44.4

Food Service – Egg

7.66.27.7

Food Service – Other

0.61.21.1

Segment Overview

SegmentSegment assetsD&AIncrease in fixed assets

Retail Market

118,9085,4474,248

Food Service

132,0676,4104,691

Overseas

104,6563,8346,455

Fruit Solutions

18,017865384

Fine Chemicals

10,916458643

Common Business

41,682986406

Segment Revenue

Segment1H FY2025 sales1H FY2026 sales1H FY2025 OI1H FY2026 OI

Retail Market

94.695.65.78.4

Food Service

89.193.84.46.9

Overseas

49.453.67.96.9

Fruit Solutions

8.68.80.30.4

Fine Chemicals

6.26.6-0.20.0

Common Business

4.03.20.70.5

Company-wide

——-2.6-3.0

Total

251.9261.616.220.0

Income Statement

Metric (JPY Mn)FY2021FY2022FY2023FY2024FY2025

Net sales

407,039430,304455,086483,985513,417

Cost of sales

282,807306,114332,755336,217362,490

Gross profit

124,232124,189122,330147,767150,927

SG&A

96,26098,755102,636113,437116,298

Operating income

27,97225,43319,69434,32934,628

Ordinary income

29,69827,24920,49036,87437,389

Extraordinary gains

1,4861,5854,17845312,589

Extraordinary losses

2,3232,2032,5933,6892,461

Pre-tax income

28,86026,63022,07533,63847,517

Income taxes

8,5908,2646,5509,22813,627

Net income attributable to owners

18,01416,03313,17421,41930,506

Depreciation and amortisation

15,53416,24917,11717,53618,291

EBITDA (OI + D&A)

43,50641,68236,81151,86552,919

Per-share data (JPY)

Per-share data (JPY)FY2021FY2022FY2023FY2024FY2025

EPS basic

128.2115.3494.78154.10220.63

EPS diluted

128.2115.3494.78154.10220.63

Dividends per share

4747505464

Book value per share

1,767.131,925.542,027.902,174.742,328.49

Margins (%)

Margins (%)FY2021FY2022FY2023FY2024FY2025

Gross margin

30.528.926.930.529.4

Operating margin

6.95.94.37.16.7

EBITDA margin

10.79.78.110.710.3

Net margin

4.43.72.94.45.9

Balance Sheet and Margin Analysis (%)

Metric (JPY Mn)FY2021FY2022FY2023FY2024FY2025

Total assets

381,003403,384426,006462,372480,531

Cash and deposits

58,34357,82566,61078,13965,598

Securities (short-term)

10,00010,0002,00010,00015,000

Cash & equivalents (cash flow basis)

66,70265,33562,43380,51265,849

Receivables

56,73859,29964,14571,19474,380

Inventories

30,06537,07743,99339,86142,262

Total current assets

157,451167,726182,080203,727203,365

Total current liabilities

71,19965,25281,37291,239104,979

Working capital

86,252102,474100,708112,48898,386

Short-term debt incl. current portion of bonds

11,5913,05817,2002,27117,202

Long-term debt incl. bonds

26,35626,07010,78415,5000

Lease obligations (long-term)

3,7803,3373,8073,7853,592

Total debt

41,72732,46531,79121,55620,794

Net debt (negative = net cash)

-26,616-35,360-36,819-66,583-59,804

Goodwill

552364182073

Other intangibles

12,75115,27515,62519,00317,599

Shareholders' equity (owners)

245,640267,657281,884302,292324,064

Non-controlling interests

23,66026,96529,41929,34623,536

Total net assets

269,301294,623311,303331,638347,600

Equity ratio (%)

64.566.466.265.467.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Cash Flow

Metric (JPY Mn)FY2021FY2022FY2023FY2024FY2025

Operating cash flow

38,53327,19923,72563,12631,802

Purchase of tangible fixed assets

7,74312,48215,16418,12415,594

Purchase of intangible fixed assets

3,8424,3232,2815,803936

Investing cash flow

-20,277-15,947-17,721-23,893-16,905

Financing cash flow

-18,701-16,812-9,514-21,126-30,102

Free cash flow (OCF minus capex incl. intangibles)

26,94810,3946,28039,19915,272

Free cash flow (company definition: OCF + ICF)

18,25611,2526,00439,23314,897

Dividends paid (owners)

5,6656,5336,9506,9508,757

Dividends paid to non-controlling interests

———2,6233,420

Share buybacks

10,00412416,288

Capital investments (company accrual basis)

——17,80020,60016,900

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2021FY2022FY2023FY2024FY2025

ROE (%)

7.46.24.87.39.7

ROA – net income / avg assets (%)

4.74.03.14.66.3

ROA – ordinary income / assets, company definition (%)

—6.94.98.37.9

ROIC – company definition (%)

—5.54.16.86.6

Current ratio (x)

2.212.572.242.231.94

Debt / equity – total debt / net assets (x)

0.150.110.100.060.06

Net debt / EBITDA (x)

-0.61-0.85-1.00-1.28-1.13

Interest coverage – EBIT / interest expense (x)

116.199.750.1116.4130.7

Interest coverage – OCF / interest paid, company (x)

159.0110.661.1202.5113.0

Asset turnover – sales / year-end assets (x)

1.071.071.071.051.07

DSO (days)

50.950.351.453.752.9

DIO (days)

38.844.248.343.342.6

DPO (days)

36.239.436.748.645.0

Cash conversion cycle (days)

53.555.163.048.450.5

Dividend payout (%)

—40.752.835.029.0

Region net sales (JPY Mn)

Region net sales (JPY Mn)FY2024FY2025

Japan

391,785413,107

China

36,00836,945

Southeast Asia

25,88429,398

North America

20,82223,835

Other

9,48410,129

Total

483,985513,417

Region growth (%)

FY2025

—

Japan

5.4—

China

2.6—

Southeast Asia

13.6—

North America

14.5—

Other

6.8—

Overseas sales by region (JPY Bn)

Overseas sales by region (JPY Bn)FY2023FY2024FY2025FY2026F

China

31.536.036.940.9

Southeast Asia / Asia-Pacific

21.325.929.437.1

North America / the Americas

18.020.823.826.4

Other

7.59.510.112.1

Total Overseas

78.392.2100.3116.5

Revenue by Region

Overseas OI by region (JPY Bn)FY2025FY2026F1H FY20251H FY2026

China

5.56.13.12.7

Asia-Pacific

3.95.12.32.6

the Americas

3.22.61.81.0

Other

1.01.00.60.5

Total Overseas

13.614.87.96.9

Revenue by Region (FY2024–FY2025)

Region PP&E (JPY Mn)FY2024FY2025

Japan

117,705115,191

China

9,1419,115

Southeast Asia

10,48011,494

North America

9,01211,038

Other

1,0581,114

Share price (JPY)

Share price (JPY)Nov 2021Nov 2022Nov 2023Nov 2024Nov 2025

Fiscal year-end close

2,3082,4472,5803,4404,406

Recent Price Points Details

Recent price pointsValue

31 May 2026 close

JPY 4,027 (company)

10 Jul 2026 close (day after 1H results)

JPY 4,380 (−2.45%)

17 Aug 2026 close

JPY 4,652

7 Sep 2026 close

JPY 4,647

18 Sep 2026 close

JPY 4,440

52-week range (to Aug 2026)

JPY 3,850 – 4,888

Performance to 18 Sep 2026 (approx.)

Change (%)

Since FY2024 end (Nov 2024, c.22 months)

29

Since FY2023 end (Nov 2023, c.3 years)

72

Since FY2021 end (Nov 2021, c.5 years)

92

Valuation Multiples

MultipleKewpieBasis / source

P/E (forecast FY2026)

24.0x

Kabuyoho, 18 Sep 2026 (EPS forecast JPY 184.95)

P/E (trailing, TTM EPS JPY 181)

c.24.5x

Investing.com TTM EPS; derived

P/B (actual)

1.86x

Kabuyoho, 18 Sep 2026

EV/EBITDA (TTM to May 2026)

c.10.1x

Derived: market cap ex-treasury c.JPY 605bn + NCI 25.0bn − net cash 52.7bn = EV c.577.7bn; TTM EBITDA c.57.2bn (TTM OI 38.4bn + D&A 18.8bn)

EV/Sales (TTM)

c.1.10x

Derived (TTM sales JPY 523.2bn); MarketScreener 2026E 1.11x

Dividend yield (forecast)

1.46%

Kabuyoho

Capital Markets

ItemValueSource / date

Coverage

c.12–15 analysts (sources vary)

Simply Wall St; Eulerpool

Consensus rating

Buy (e.g., 9 of 12 Buy per Eulerpool; 5 Buy / 0 Sell per Investing.com)

Aug 2026

Average 12-month target

JPY 4,894 (high 5,500, low 4,300)

Investing.com, Aug 2026

Consensus target (QUICK/IFIS-type)

JPY 4,986

Kabuyoho, 18 Sep 2026

Consensus FY2026 ordinary profit

JPY 41.08bn (vs company guidance JPY 40.0bn)

Kabuyoho

Recent broker actions

Hold, target JPY 4,400 (30 Jul 2026); Buy, target JPY 5,200 (2 Jun 2026)

Investing.com

Dividend per share (JPY)

Dividend per share (JPY)FY2021FY2022FY2023FY2024FY2025FY2026F

Interim

———233232

Year-end

———313233

Annual

474750546465

Payout ratio (%)

—40.752.835.029.035.1

Capital Programmes

ProgrammeSizeStatus

FY2021

JPY 10.0bn

Completed

Jul 2025 authorisation (offset Aohata share exchange)

FY2025 purchases JPY 16.3bn

Completed

14 Jan 2026 authorisation

Up to 4,000,000 shares (2.87%) / JPY 10.0bn; 15 Jan–30 Nov 2026; market purchases

In progress — treasury stock rose JPY 11.9bn in 1H FY2026 (to 5.15m shares at 31 May 2026); monthly progress notices through Aug 2026

Capital Instruments

InstrumentAmount (JPY Bn)Maturity / status

3rd unsecured straight bonds

10.0

Classified as current at 30 Nov 2025; to be redeemed using 4th bond proceeds

4th unsecured straight bonds (resolved 25 Dec 2025)

≤10.0

Issuance window Feb 2026; 7-year bullet; coupon ≤3.0%; pari passu

Short-term loans

7.2 (30 Nov 2025)

Decreased by JPY 7.0bn in 1H FY2026

Long-term loans

0 (30 Nov 2025)

Increased by JPY 15.0bn in 1H FY2026

Lease obligations

c.3.6

Various

Company-defined interest-bearing debt

29.7 (31 May 2026)

vs 22.6 at 31 May 2025

Analyst Conclusions

Management guidance (FY2026, unchanged since 14 Jan 2026; reaffirmed 9 Jul 2026)

MetricFY2025 actualFY2026 guidanceChange
Net sales (JPY bn)513.4530.0+3.2%
Operating income (JPY bn)34.638.0+9.7%
Ordinary income (JPY bn)37.440.0+7.0%
Net income attributable (JPY bn)30.525.5−16.4%
EPS (JPY)220.63184.95−16.2%
DPS (JPY)6465+1.6%
ROE (%)9.78.0−1.7pt
ROIC (%)6.67.1+0.5pt
Capital investment (JPY bn)16.926.2+55%
AssumptionsUSD JPY 149; RMB JPY 21; oil JPY 376/kg; eggs JPY 319/kgUSD JPY 157; RMB JPY 23; oil JPY 427/kg; eggs JPY 305/kg—

Progress: 1H FY2026 OI of JPY 20.0bn equals 52.7% of the full-year target (vs 47% in 1H FY2025); ordinary income progress 53.8%. Management absorbed a c.JPY 4.5bn Middle East headwind while maintaining guidance, relying on price revisions (incl. 1 Nov 2026), value-add, and an overseas acceleration in 2H led by Indonesia and KEWPIE-brand products in the Americas.

Consensus expectations

Consensus ordinary profit for FY2026 of JPY 41.1bn sits c.2–3% above company guidance (Kabuyoho, Sep 2026), implying the market expects a modest beat.

Bull case

  1. Structural domestic margin reset: domestic business profit margin rose from 5.4% to 7.7% in 1H FY2026; with the Nov 2026 price round followed by Ajinomoto, the ≥8.0% FY2028 target looks achievable early.

  2. Overseas operating leverage: FY2025 plant investments ("supply capacity through 2030") mean incremental Americas and Asia-Pacific volume carries high drop-through once depreciation is absorbed; FY2026F Overseas sales +16% to JPY 116.5bn.

  3. Capital efficiency upside: net cash c.JPY 53bn, debt/EBITDA ceiling of 2x, cross-shareholding sales and continued buybacks provide multiple ROE levers beyond operations.

Bear case

  1. Price elasticity: cumulative double-digit price increases (Apr and Nov 2026) in a frugal Japanese market risk volume erosion, especially in commercial channels where volume has been flat at 47k t.

  2. Overseas growth below plan: local-currency growth of 8% (FY2025) and 3% (1H FY2026) is below the ≥10% CAGR target; reaching JPY 180bn by FY2028 requires c.16% annual growth from FY2025.

  3. Valuation: at c.24x forward earnings, 1.9x book and a 1.5% yield, the shares price in successful execution; another commodity shock (oil to JPY 427/kg is already assumed) or HPAI wave could cause a de-rating.

Catalysts and monitorables (next 12 months)

TimingCatalyst / monitorable
c.8 Oct 2026Q3 FY2026 results — 2H overseas acceleration; Middle East cost absorption
Nov 2026Volume response to 1 Nov price increases; completion of JPY 10bn buyback (deadline 30 Nov 2026)
1 Dec 2026Egg-products sales integration from Kewpie Egg
Jan 2027FY2026 results; FY2027 guidance; possible new buyback and DPS step-up
Feb 2027114th AGM
OngoingTennessee line additions (3 of 6 lines at opening); Indonesia growth; China profitability
OngoingEgg benchmark and edible-oil prices; HPAI season (winter 2026–27)
OngoingAny M&A under the MTP's growth-investment provision

Concluding analyst verdict

Kewpie has moved decisively out of the 2022–2023 commodity crisis and into what management calls a "profit expansion phase". The evidence is persuasive at the operating line: three consecutive years of record operating income, a domestic margin rebuilt from 5.4% to 7.7% within a year, and full-year guidance held despite a c.JPY 4.5bn Middle East shock. The company's ability to lead industry price rounds — with Ajinomoto following within days in September 2026 — confirms that its brand franchise in Japanese mayonnaise and dressings retains genuine pricing power, and the egg business is shifting from commodity exposure towards value-added products.

The investment debate therefore centres less on domestic resilience than on two medium-term questions. First, can the Overseas segment convert heavy recent capex (Tennessee, China, Thailand, Indonesia) into the double-digit local-currency growth the plan requires? 1H FY2026 growth of 3% and a 13% profit decline argue for patience rather than conviction, though management attributes the slowdown to temporary factors and depreciation timing. Second, can capital efficiency reach the 8.5% ROIC target when the balance sheet remains under-levered and R&D intensity is low? Recent actions — Aohata's full ownership, a JPY 10bn buyback, unwinding cross-shareholdings, and the Kewpie Egg sales integration — show a management team willing to restructure, but the underlying ROE (excluding property gains) is still around 8%.

At roughly 24x forward earnings and 1.9x book, the shares already discount a good part of the domestic recovery. The risk-reward is balanced to modestly positive: upside requires visible overseas acceleration in 2H FY2026 and FY2027 plus a clearer plan to deploy surplus capital, while downside is cushioned by balance-sheet strength and dividend support. We would characterise Kewpie as a high-quality, execution-dependent compounder — attractive on weakness, with Q3 FY2026 results and post-price-increase volume trends as the key near-term tests.


Derived figures (FY2021 EPS, FY2021 and FY2025 share prices, EV/EBITDA, CCC, segment FY2023 splits) are labelled as such. Where aggregator data conflict with filings (e.g., D&A, EBITDA, total debt definitions), filing figures are preferred and discrepancies noted.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NamePositionIndependenceTenure / career highlightsAge

Amane Nakashima

Director, Chairman; Chair of the Board; in charge of Brand

Non-independent (Representative Director & President of Nakashimato Co., Ltd., a major shareholder and trading counterparty)

Industrial Bank of Japan (1983); Nakashimato (1993); Kewpie Director (Feb 1997); Head of CSR Promotion (Oct 2009); Nakashimato President (Feb 2010); Kewpie Senior Managing Director (Feb 2014); Chairman (Feb 2016–); Nakashimato Rep. Director & President (Feb 2021–). Holds c.250,519 Kewpie shares (0.18%). Board attendance FY2025: 11/11

67 (born 26 Sep 1959)

Mitsuru Takamiya

Representative Director, President & Chief Executive Corporate Officer

Executive

Joined Kewpie Apr 1987 (R&D background); Corporate Officer (Feb 2013); Senior Corporate Officer (Feb 2019); senior role at Kewpie Egg; Representative Director & President (Feb 2022–). 11/11

c.65

Ryuta Watanabe

Director, Managing Executive Officer; Supply Chain Management

Executive

Director since Feb 2021. 11/11

c.62

Shinichiro Yamamoto

Director, Managing Executive Officer; Corporate (finance/IR — presents results)

Executive

Previously Director, Senior Corporate Officer; MTP contact person. 11/11

—

Shinya Hamasaki

Director, Managing Executive Officer; Group Sales and Retail Market

Executive

Former Senior Corporate Officer and CEO of Q&B Foods (2022). 11/11

—

Hitoshi Kashiwaki

Outside Director

Independent; Chair of Nomination & Compensation Committee

Former President & CEO of Recruit (per public biographies). 11/11

—

Atsuko Fukushima

Outside Director

Independent

Journalist/broadcaster (per public biographies)

—

Kuniko Nishikawa

Outside Director

Independent

Outside director since 2024 AGM (9/10 meetings after appointment in FY2024)

—

Harold George Meij

Outside Director

Independent

Former consumer-company chief executive (incl. Takara Tomy and New Japan Pro-Wrestling, per public biographies). 10/10 after appointment in FY2024

—

Executive Leadership Team

NameTitleSource

Takumi Tomita

Corporate Officer, Accounting & Finance (CFO-equivalent; filings contact)

Kessan Tanshin

Motoki Tanaka

Corporate Officer, Head of Management Promotion Division

Extraordinary Report (Jul 2026)

Ken Nakajima

Corporate Officer, Head of Marketing Division

AdverTimes (Jan 2026)

Hiroaki Ogita (扇田博昭)

Representative Director & President, Kewpie Egg Corporation

Extraordinary Report (Jul 2026)

Toshiya Ueda

Representative Director & President, AOHATA Corporation (from Feb 2025; ex-Kewpie Production Division head)

Aohata Annual Securities Report

Jerry Shepherd

President, Q&B Foods

Clarksville Now (2025)

Governance Overview

ItemDetail

Board size

9 directors

Independent outside directors

4 of 9 (44%)

Women on board

2 of 9 (22%)

Non-Japanese directors

1 (Harold George Meij)

Chair / CEO separation

Yes — Chairman Nakashima chairs the Board; Takamiya is CEO

Committees

Voluntary Nomination & Compensation Committee chaired by outside director Kashiwaki; Audit & Supervisory Board (statutory)

Board meetings FY2025

11 (all directors standing for re-election attended 11/11)

Governance report

Corporate Governance Report last updated 27 Feb 2026

Board & Management Changes

DateChangeContext

Feb 2022

Mitsuru Takamiya appointed President & CEO

Leadership transition during the commodity crisis

Feb 2025

Toshiya Ueda (Kewpie production head) became Aohata President

Group integration ahead of full ownership

Feb 2026

Corporate auditors Isono and Unemoto appointed; Oda and Terawaki retired

Routine rotation

Feb 2026

All nine directors re-elected

Board continuity

Major Shareholders

RankShareholderShares (thousand)Stake (%)
1

The Master Trust Bank of Japan (trust account)

16,89312.14
2

Nakashimato Co., Ltd.

11,4528.23
3

Toka Co., Ltd. (株式会社董花)

11,1227.99
4

Custody Bank of Japan (trust account)

8,2365.92
5

Kieikai Foundation (一般財団法人旗影会)

4,2513.06
6

Dai-ichi Life Insurance

3,0742.21
7

Nippon Life Insurance

3,0492.19
8

Nakato Scholarship Foundation (公益財団法人中董奨学会)

2,4941.79
9

Kewpie Employee Shareholding Association

2,1291.53
10

T&A Co., Ltd.

2,0491.47

Competitive Landscape

Competitors by Segment

SegmentCompetitorListingRelative positioning

Mayonnaise (Japan retail/food service)

Ajinomoto Co. ("Pure Select" mayonnaise)

TSE 2802

Clear No.2 in Japanese mayonnaise; much larger diversified group

Mayonnaise/dressings/delis (food service)

Kenko Mayonnaise

TSE 2915

Food-service specialist; mayonnaise, salads, egg products

Dressings (Japan)

Riken Vitamin (non-oil dressings)

TSE 4526

Strong in non-oil dressings

Dressings / oils (Japan)

Nisshin OilliO Group

TSE 2602

Oils and dressings; also an input supplier

Vinegar / condiments

Mizkan Holdings

Private

Vinegar and condiment leader; competes with Kewpie Jozo

Soy-based condiments / global Japanese seasonings

Kikkoman

TSE 2801

Benchmark for global Japanese condiment expansion

Sauces / curry / packaged foods

House Foods Group

TSE 2810

Competes in retail sauces; formerly baby/infant foods

Egg products (Japan)

Ise Foods and other egg processors

Private

Shell-egg and egg-product competition

Mayonnaise (U.S./global)

Unilever (Hellmann's/Best Foods)

LSE/NYSE

Global leader in mayonnaise

Condiments (U.S./global)

Kraft Heinz

Nasdaq

Mayonnaise, dressings, sauces

Condiments (U.S./global)

McCormick

NYSE

Mayonnaise (Asia/Europe brands), sauces

Jams (Japan)

——

Aohata is a leading domestic jam brand

Hyaluronic acid

Various chemical/biotech firms (not specified in sources)

—

Kewpie is a niche B2B supplier

Peer Comparison FY2011

MetricKewpie (FY11/2025)Ajinomoto (FY3/2026)Kikkoman (FY3/2026)Kenko Mayonnaise (FY3/2026)

Revenue (JPY Bn)

513.41,583.7745.592.4

Revenue growth (%)

6.13.55.20.7

Operating margin (%)

6.710.110.24.5

Business profit margin (%)

—11.410.7—

R&D intensity (%)

0.742.0——

ROE (%)

9.7—11.57.2

Accounting standard

J-GAAP

IFRS

IFRS

J-GAAP

Company Snapshot

$4,717.9M

Revenue

10,773

Employees

1919

Founded

Tokyo, Japan

Headquarters

SWOT Analysis

Strengths

  • Record and rising profitability: operating income reached a record JPY 34.6bn in FY2025 (third consecutive record) and 1H FY2026 OI rose 23.9% to JPY 20.0bn (FY2025 and 1H FY2026 Kessan Tanshin).
  • Pricing power: household salad-condiment unit price +6% to JPY 655/kg in 1H FY2026 with volume held at 62k t (Supplementary Data 1H FY2026).
  • High-margin overseas business: Overseas segment margin 13.6% in FY2025 vs consolidated 6.7% (FY2025 Kessan Tanshin).
  • Fortress balance sheet: equity ratio 67.4%, net cash c.JPY 59.8bn at FY2025; EBIT/interest >100x.
  • Vertical integration in eggs: egg products sales JPY 115.8bn with value-added items growing in volume (1H FY2026 briefing).
  • Diversified channel mix: Retail (37.0%) and Food Service (36.1%) of FY2025 sales; no customer ≥10% of sales.
  • Shareholder-return commitment: total return ratio ≥50%, minimum DPS JPY 54, JPY 26bn+ of buybacks authorised/executed across FY2025–FY2026.

Weaknesses

  • Domestic volume stagnation: commercial salad-condiment volume 47k t in 1H FY2024, 1H FY2025 and 1H FY2026 (Supplementary Data 1H FY2026).
  • Commodity sensitivity: FY2023 OI fell 22.6% to JPY 19.7bn when egg and oil prices spiked (Kabuyoho/Kessan history).
  • Low R&D intensity: 0.74% of sales in FY2025 vs c.2.0% at Ajinomoto.
  • ROIC below target: 6.6% (FY2025) vs ≥8.5% FY2028 target.
  • Low-margin sub-businesses: cut vegetables (OI JPY 0.8bn on JPY 30.0bn sales, FY2025), Fruit Solutions (3.9% margin).
  • Overseas profit drag from new capacity: 1H FY2026 Overseas OI −13% on depreciation of new U.S. and China plants (FilingReader summary of 1H results).

Opportunities

  • Americas scale-up: Tennessee plant running 3 of 6 lines at opening, with capacity up to 3x U.S. production and a mandate to serve North and South America (Food Business News, May 2025).
  • Asia-Pacific middle class: Asia-Pacific FY2026F sales JPY 37.1bn (+26%) led by Indonesia (Supplementary Data 1H FY2026).
  • Egg-sales integration: c.JPY 7.8bn transfer from 1 Dec 2026 to streamline food-service sales (Extraordinary Report, Jul 2026).
  • Capital efficiency levers: unused debt capacity (target debt/EBITDA <2x vs net cash) and cross-shareholding sales (SMBC exit from top 10).
  • Health/functional foods: Fine Chemicals sales +5.6% in 1H FY2026 on mail-order supplements (Envalith summary).
  • Value-added food-service sauces: Gutappuri Sauce series expanded to 5 SKUs since Feb 2024 (news release Jan 2026).
  • M&A optionality: MTP explicitly allows M&A for overseas growth and new domains.

Threats

  • Middle East-driven cost inflation: c.JPY 4.5bn FY2026 OI headwind (1H FY2026 briefing materials).
  • Edible-oil price rise: institutional oil forecast JPY 427/kg in FY2026 vs JPY 376/kg in FY2025 (Supplementary Data 1H FY2026).
  • HPAI recurrence: egg benchmark remained elevated at JPY 305–334/kg (FY2025–FY2026).
  • Consumer trade-down after repeated price rises: the company cites consumer frugality; November 2026 increases of up to 25% (household) and 38% (commercial) risk volume loss.
  • China competition: China OI −JPY 0.4bn in 1H FY2026.
  • Global incumbents overseas: Unilever (Hellmann's), Kraft Heinz and McCormick dominate Western mayonnaise shelves.
  • Japanese demographic decline: contributed to the baby-food exit (births below 700,000 in 2024).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
3 Apr 2025Q1 FY2025: sales JPY 120.0bn (+4.7%), OI JPY 5.79bn (−29.0%), net profit JPY 12.78bn (+111.6%) on factory-site gainEgg and vegetable costs hit margins before price revisions took effect
20 May 2025Tennessee plant opening ceremony (production from 22 May); CEO says it will become the base for all of North and South AmericaU.S. capacity up to 3x
Jun 2025Announced end of baby-food production (72 items) at end Aug 2026Exit from 65-year-old category
3 Jul 20251H FY2025 results (sales JPY 251.9bn, OI JPY 16.2bn); Aohata share-exchange agreement; buyback resolution to offset dilutionGroup simplification; capital efficiency
25 Sep 2025Aohata EGM approves share exchangeDeal certainty
2 Oct 2025Q3 FY2025: 9M ordinary income JPY 29.2bn (−9.2%); full-year guidance heldCost headwinds persisted
30 Oct 2025Aohata delisted from TSE Standard—
1 Nov 2025Aohata becomes wholly owned (4.15m treasury shares delivered)Minority leakage reduced
25 Dec 2025Board resolves 4th unsecured bonds (≤JPY 10bn, 7-year, ≤3.0%) to refinance 3rd bondsDebt refinancing at higher-rate environment
13 Jan 2026Food-service launches: Gutappuri Sauce negi-shio; Gutakusan Sauce Lemon Tartar (on sale 6 Feb)Value-added food-service sauces
14 Jan 2026FY2025 results: record OI JPY 34.6bn; net JPY 30.5bn (+42.4%); FY2026 guidance sales JPY 530bn, OI JPY 38bn; DPS JPY 65 plannedThird consecutive record OI
14 Jan 2026Buyback authorised: up to 4m shares / JPY 10bn (15 Jan–30 Nov 2026)Shareholder returns
27 Jan 2026New-product strategy briefing — 2026 theme "CROSS"Marketing integration
3 Feb 2026Thousand Island dressing renewal (on sale 19 Feb)Core-product refresh
6 Feb 2026FY2025 year-end dividend JPY 32 paid—
24 Feb 2026113th-period Annual Securities Report filedStatutory
26 Feb 2026113th AGM: 9 directors, 2 auditors electedGovernance continuity
1 Apr 2026Price revisions effective (Kewpie items up to c.24% per Teikoku Databank-based coverage)Cost pass-through
9 Apr 2026Q1 FY2026: sales JPY 124.7bn (+3.9%), OI JPY 7.81bn (+35.0%), net JPY 5.39bn (−57.8%, lapping gain)Domestic margin recovery
27 Apr 2026Integrated Report 2026 published (theme "Change & Challenge")Disclosure
1 May – 3 Aug 2026Monthly buyback progress noticesExecution of JPY 10bn programme
2 Jun 2026Broker maintains Buy, target raised to JPY 5,200 (Investing.com)Sentiment
9 Jul 20261H FY2026: sales JPY 261.6bn (+3.9%), OI JPY 20.0bn (+23.9%), net JPY 13.2bn (−29.7%); full-year guidance maintained despite c.JPY 4.5bn Middle East headwind; interim DPS JPY 32Domestic "¥6.0bn synergy" from value-add and pricing; overseas OI −13%
13 Jul 2026Semi-annual securities report filedStatutory
29 Jul 2026Board resolves to acquire Kewpie Egg's egg-products sales business (c.JPY 7.8bn; 1 Dec 2026)Sales-organisation efficiency
30 Jul 2026Broker maintains Hold, target raised from JPY 4,100 to 4,400 (Investing.com)Sentiment
Aug 2026Baby-food production scheduled to endPortfolio exit
1 Sep 2026Announced price increases: 224 household items +c.3–25% (1 Nov shipments; mayonnaise 450g JPY 559→611) and 601 commercial items +c.2–38%, citing Middle East-related raw-material and packaging costs; shares hit a high after the announcementSecond price round of 2026
9 Sep 2026Ajinomoto announces mayonnaise price increase of c.6–10% from 1 Dec 2026Competitor follows — supports price realisation
18 Sep 2026Share price JPY 4,440 (−3.35% on day); forward P/E 24.0x; consensus ordinary profit JPY 41.08bnValuation context
c.8 Oct 2026 (scheduled)Q3 FY2026 resultsNext catalyst; not yet available at preparation

Product Offering

  • KEWPIE CORPORATION
    • Hyaluronic acid

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

11 charts
Income Statement: Revenue & Gross Profit: Net sales rose from JPY 407 Bn in FY2021 to JPY 513.4 Bn in FY2025.
KEWPIE CORPORATION — Income Statement: Revenue & Gross Profit
Series (JPY Bn)FY2021FY2022FY2023FY2024FY2025
Net sales407430.3455.1484513.4
Cost of sales282.8306.1332.8336.2362.5
Gross profit124.2124.2122.3147.8150.9

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.